Diproteverine
From Wikipedia, the free encyclopedia
 |
|
|
Diproteverine
|
|
| Systematic (IUPAC) name | |
| 1-[(3,4-diethoxyphenyl)methyl]-6,7-dipropan-2- yloxy-3,4-dihydroisoquinoline |
|
| Identifiers | |
| CAS number | 69373-88-2 (hydrochloride) |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C26H35NO4 |
| Mol. mass | 425.56 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Diproteverine (usually as diproteverine hydrochloride) is a calcium channel blocker.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
